Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belinda S Cowling

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Disease Models & Mechanisms|October 30, 2019
Translational medicine in neuromuscular disorders: from academia to industryBelinda S Cowling, Leen Thielemans
Journal of Molecular Medicine (Berlin, Germany)|March 5, 2014
Amphiphysin 2 (BIN1) in physiology and diseasesIvana Prokic, Belinda S Cowling, Jocelyn Laporte
Journal of Neuromuscular Diseases|August 15, 2018
Centronuclear myopathies under attack: A plethora of therapeutic targetsHichem Tasfaout, Belinda S Cowling, Jocelyn Laporte
International Journal of Molecular Sciences|November 13, 2021
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment AdvancesRaquel Gómez-Oca, Belinda S Cowling, Jocelyn Laporte
Plos Genetics|April 13, 2012
Defective membrane remodeling in neuromuscular diseases: insights from animal modelsBelinda S Cowling, Anne Toussaint, Jean Muller, et al.
Advances in Biological Regulation|September 27, 2016
WANTED - Dead or alive: Myotubularins, a large disease-associated protein familyMatthieu A Raess, Sylvie Friant, Belinda S Cowling, et al.
Human Molecular Genetics|October 20, 2019
Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathyXènia Massana Muñoz, Suzie Buono, Pascale Koebel, et al.
Journal of Cell Science|March 29, 2007
FHL3 binds MyoD and negatively regulates myotube formationDenny L Cottle, Meagan J McGrath, Belinda S Cowling, et al.
Neuromuscular Disorders : NMD|February 12, 2011
Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological featuresBelinda S Cowling, Denny L Cottle, Brendan R Wilding, et al.
Molecular Therapy. Nucleic Acids|March 30, 2019
Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell PhenotypesAymen Rabai, Léa Reisser, Bernardo Reina-San-Martin, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Disease Models & Mechanisms|October 30, 2019
Translational medicine in neuromuscular disorders: from academia to industryBelinda S Cowling, Leen Thielemans
Journal of Molecular Medicine (Berlin, Germany)|March 5, 2014
Amphiphysin 2 (BIN1) in physiology and diseasesIvana Prokic, Belinda S Cowling, Jocelyn Laporte
Journal of Neuromuscular Diseases|August 15, 2018
Centronuclear myopathies under attack: A plethora of therapeutic targetsHichem Tasfaout, Belinda S Cowling, Jocelyn Laporte
International Journal of Molecular Sciences|November 13, 2021
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment AdvancesRaquel Gómez-Oca, Belinda S Cowling, Jocelyn Laporte
Plos Genetics|April 13, 2012
Defective membrane remodeling in neuromuscular diseases: insights from animal modelsBelinda S Cowling, Anne Toussaint, Jean Muller, et al.
Advances in Biological Regulation|September 27, 2016
WANTED - Dead or alive: Myotubularins, a large disease-associated protein familyMatthieu A Raess, Sylvie Friant, Belinda S Cowling, et al.
Human Molecular Genetics|October 20, 2019
Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathyXènia Massana Muñoz, Suzie Buono, Pascale Koebel, et al.
Journal of Cell Science|March 29, 2007
FHL3 binds MyoD and negatively regulates myotube formationDenny L Cottle, Meagan J McGrath, Belinda S Cowling, et al.
Neuromuscular Disorders : NMD|February 12, 2011
Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological featuresBelinda S Cowling, Denny L Cottle, Brendan R Wilding, et al.
Molecular Therapy. Nucleic Acids|March 30, 2019
Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell PhenotypesAymen Rabai, Léa Reisser, Bernardo Reina-San-Martin, et al.
Pageof 5